Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Fennec Pharmaceuticals Inc. FENC

Full chart Compare
Set alert

Price alert · FENC

All alert types
10.70 USD +0.16 (+1.52%)

At closeNov 3, 2026, 4:00 PM EST

10.70 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

10.22 Day range 10.83
5.65 52-week range 13.25
YTD
+38.96%
1 year
+31.61%

Financial health

Altman Z-Score

4.18 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -21.4×
FY 2016: -54.5×FY 2017: -21.3×FY 2018: -12.3×FY 2019: -10.3×FY 2020: -9.8×FY 2021: -6.6×FY 2022: -10.1×FY 2023: -18.7×FY 2024: -395×FY 2025: -21.4×
FY 2016 5y median -18.7× FY 2025
P/S 4.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 1039×FY 2021: 0.0×FY 2022: 164×FY 2023: 14.0×FY 2024: 3.6×FY 2025: 4.9×
FY 2016 5y median 4.9× FY 2025
P/B 6.3×
FY 2016: 42.6×FY 2017: 5.6×FY 2018: 5.7×FY 2019: 10.9×FY 2020: 6.1×FY 2021: 7.3×FY 2022: -98.2×FY 2023: -25.7×FY 2024: -29.4×FY 2025: 6.3×
FY 2016 5y median -25.7× FY 2025
P/FCF -17.6×
FY 2016: -71.6×FY 2017: -41.3×FY 2018: -15.4×FY 2019: -14.3×FY 2020: -11.3×FY 2021: -8.0×FY 2022: -14.0×FY 2023: -17.4×FY 2024: 6.4×FY 2025: -17.6×
FY 2016 5y median -14.0× FY 2025
EV/EBITDA -24.6×
FY 2016: 1283×FY 2017: -350×FY 2018: 95.7×FY 2019: -8.8×FY 2020: -8.3×FY 2021: -5.7×FY 2022: -11.2×FY 2023: -25.5×FY 2024: 34.4×FY 2025: -24.6×
FY 2016 5y median -11.2× FY 2025
EV/Sales 4.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 860×FY 2021: 0.0×FY 2022: 165×FY 2023: 14.9×FY 2024: 3.5×FY 2025: 4.1×
FY 2016 5y median 4.1× FY 2025
FCF Yield -5.7%
FY 2016: -1.4%FY 2017: -2.4%FY 2018: -6.5%FY 2019: -7.0%FY 2020: -8.8%FY 2021: -12.4%FY 2022: -7.2%FY 2023: -5.7%FY 2024: 15.6%FY 2025: -5.7%
FY 2016 5y median -5.7% FY 2025

Profitability

Gross Margin 91.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 100.0%FY 2021: 0.0%FY 2022: 94.4%FY 2023: 94.1%FY 2024: 93.3%FY 2025: 91.6%
FY 2016 5y median 93.3% FY 2025
Operating Margin -14.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -10520.6%FY 2021: 0.0%FY 2022: -1481.3%FY 2023: -61.4%FY 2024: 5.2%FY 2025: -14.2%
FY 2016 5y median -14.2% FY 2025
Net Margin -21.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -10652.4%FY 2021: 0.0%FY 2022: -1544.9%FY 2023: -75.5%FY 2024: -0.9%FY 2025: -21.8%
FY 2016 5y median -21.8% FY 2025
ROE -27.8%
FY 2016: -78.1%FY 2017: -26.3%FY 2018: -46.4%FY 2019: -110.1%FY 2020: -62.3%FY 2021: -110.0%FY 2022: 923.1%FY 2023: 138.1%FY 2024: 7.4%FY 2025: -27.8%
FY 2016 5y median 7.4% FY 2025
ROIC -10.7%
FY 2016: -80.2%FY 2017: -25.8%FY 2018: -47.1%FY 2019: -112.1%FY 2020: -61.5%FY 2021: -83.0%FY 2022: -101.8%FY 2023: -67.5%FY 2024: 6.5%FY 2025: -10.7%
FY 2016 5y median -67.5% FY 2025
ROA -13.9%
FY 2016: -70.2%FY 2017: -24.8%FY 2018: -43.1%FY 2019: -92.4%FY 2020: -57.6%FY 2021: -77.4%FY 2022: -88.0%FY 2023: -59.7%FY 2024: -1.0%FY 2025: -13.9%
FY 2016 5y median -59.7% FY 2025

Growth (YoY)

Revenue -6.1%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 1284.5%FY 2024: 123.7%FY 2025: -6.1%
FY 2016 FY 2025
Operating Income -356.0%
FY 2016: -51.9%FY 2017: -142.1%FY 2018: -49.7%FY 2019: -27.9%FY 2020: -34.4%FY 2021: 3.7%FY 2022: -32.0%FY 2023: 42.6%FY 2024: 119.0%FY 2025: -356.0%
FY 2016 FY 2025
EPS (diluted) -2150.0%
FY 2016: -261.2%FY 2017: -113.6%FY 2018: -10.6%FY 2019: -21.2%FY 2020: -20.6%FY 2021: 11.8%FY 2022: -41.8%FY 2023: 36.8%FY 2024: 97.3%FY 2025: -2150.0%
FY 2016 FY 2025
Free Cash Flow -146.2%
FY 2016: -14.1%FY 2017: -71.4%FY 2018: -114.9%FY 2019: -15.8%FY 2020: -72.1%FY 2021: 8.8%FY 2022: -27.0%FY 2023: 5.1%FY 2024: 257.4%FY 2025: -146.2%
FY 2016 FY 2025

Financial Health

Current Ratio 6.3×
FY 2016: 9.9×FY 2017: 17.3×FY 2018: 14.0×FY 2019: 6.1×FY 2020: 13.4×FY 2021: 13.5×FY 2022: 5.8×FY 2023: 3.6×FY 2024: 6.4×FY 2025: 6.3×
FY 2016 5y median 6.3× FY 2025
Quick Ratio 6.2×
FY 2016: 9.9×FY 2017: 17.3×FY 2018: 14.0×FY 2019: 6.1×FY 2020: 13.4×FY 2021: 13.5×FY 2022: 5.7×FY 2023: 3.3×FY 2024: 6.2×FY 2025: 6.2×
FY 2016 5y median 6.2× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.3×FY 2022: -9.7×FY 2023: -2.7×FY 2024: -3.3×FY 2025: 0.0×
FY 2016 5y median -2.7× FY 2025
Net Debt / EBITDA 4.9×
FY 2016: -34.0×FY 2017: 81.1×FY 2018: -22.2×FY 2019: 1.0×FY 2020: 1.7×FY 2021: 0.9×FY 2022: -0.0×FY 2023: -1.4×FY 2024: -1.5×FY 2025: 4.9×
FY 2016 5y median -0.0× FY 2025
Interest Coverage -3.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -137×FY 2022: -23.2×FY 2023: -3.8×FY 2024: 0.6×FY 2025: -3.1×
FY 2016 5y median -3.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31